Abstract:Context: Obstructive sleep apnea (OSA) has been increasingly implicated in the initiation and progression of cardiovascular diseases. Objective: To systematically review the interactions of OSA with cardiovascular pathophysiology and diseases. Data sources and study selection: The MEDLINE database from January 1966 to March 2003 was searched using the Medical Subject Headings sleep, sleep apnea, obesity, hypertension, heart failure, cardiac arrhythmia, coronary artery disease, stroke, sympathetic activity, endothelium, inflammation, and continuous positive airway pressure (CPAP) to identify peer-reviewed studies of OSA. Priority was given to large prospective cohort studies and to randomized controlled trials. Data extraction: We identified 154 original investigations and reviews of sleep-related breathing disorders. Data from these studies were examined for relevance and extracted by one of the authors. Data synthesis: Approximately 1 in 5 adults has at least mild OSA (apnea-hypopnea index [ie, the number of apneic and hypopneic events per hour], 5-15), and 1 in 15 adults has at least moderate OSA (apnea-hypopnea index, 15-30). Repetitive apneic events disrupt the normal physiologic interactions between sleep and the cardiovascular system. Such sleep fragmentation, as well as abnormalities evident in patients with OSA (eg, increased sympathetic activation, vascular endothelial dysfunction, increased oxidative stress, inflammation, increased platelet aggregability, metabolic dysregulation), may be implicated in the initiation and progression of cardiac and vascular disease. Persuasive data implicate OSA in the development of hypertension, and OSA also may contribute to cardiac ischemia, congestive heart failure, cardiac arrhythmias, and perhaps also to cerebrovascular disease and stroke. Conclusions: Obstructive sleep apnea is common, readily diagnosed, and usually treatable. It frequently coexists undiagnosed in patients with cardiovascular disease, activates disease mechanisms known to elicit cardiac and vascular damage, and may be implicated in progression of cardiovascular disease and resistance to conventional therapeutic strategies. In the absence of definitive evidence from large-scale trials and a better understanding of potential cost-effectiveness, the likely benefits of diagnosis and treatment of OSA are presently best appraised on an individualized patient basis.

[Progress in obstructive sleep apnea and atherosclerosis]

An Update on Obstructive Sleep Apnea for Atherosclerosis: Mechanism, Diagnosis, and Treatment

Association Between Obstructive Sleep Apnea and Cardiovascular Diseases.

Research progress on the relationship between obstructive sleep apnea syndrome and diseases of the respiratory and circulatory systems

Obstructive Sleep Apnea in Coronary Artery Disease

Development of the Research on the Inflammatory Factors Related to Obstructive Sleep Apnea Hypopnea Syndrome and Therapy

The latest research progress on the relationship between obstructive sleep apnea–hypopnea syndrome and metabolic syndrome

Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome

Progresses in Clinical and Basic Research of Myocardial Injury Caused by Obstructive Sleep Apnea

Research progress on the role of exosomes in obstructive sleep apnea-hypopnea syndrome-related atherosclerosis

Obstructive sleep apnea: implications for cardiac and vascular disease

Advances in Research on the Mechanism of Obstructive Sleep Apnea on Olfactory Function

The Research Progress of Obstructive Sleep Apnea-Hypopnea Syndrome and Hypothalamic-Pituitary-adrenal Axis

The Research Progress of Obstructive Sleep Apnea Hypopnea Syndrome and Thyroid Disease

Obstructive sleep apnoea and cardiovascular complications: perception versus knowledge.

Obstructive Sleep Apnea-Hypopnea and Cardiovascular Diseases in Adults

Advances in Multimodal Echocardiographic Evaluation of Ischemic Cardiomyopathy due to Obstructive Sleep Apnea Syndrome

Obstructive sleep apnea syndrome (OSAS) and hypertension: Pathogenic mechanisms and possible therapeutic approaches

Obstructive Sleep Apnea Syndrome and Metabolic Diseases

Research Progress of the Role of T Lymphocytes in Obstructive Sleep Apnea Syndrome-Related Atherosclerosis

Obstructive sleep apnea hypopnea syndrome and vascular lesions: An update on what we currently know